医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Taro to Announce First Quarter Results on August 9, 2018

2018年08月03日 AM02:44
このエントリーをはてなブックマークに追加


 

HAWTHORNE, N.Y.

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2018, after the close of market on Thursday, August 9, 2018.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180802005744/en/

CONTACT

Taro Pharmaceutical Industries Ltd.
Mariano A. Balaguer
VP,
CFO
914-345-9001
Mariano.Balaguer@taro.com
or
William
J. Coote

AVP, Business Finance, Treasurer and Investor Relations
914-345-9001
William.Coote@taro.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • ROSALIND, HELiXrUS and Geninus Partner to Bring Powerful New Single Cell Analysis Services to Cancer Researchers
  • Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
  • LintonPharm、筋層非浸潤性膀胱がんの治療薬としてカツマキソマブを評価する第1/2相試験の実施を中国の保健当局(NMPA)が承認したと発表
  • ルーブリック・セラピューティクスがザイ・ラボとの研究協力・ライセンスオプション契約を発表
  • Prestige Biopharma and Pharmapark Announce License and Supply Agreement to Commercialize Prestige’s Bevacizumab Biosimilar in the Russian Federation